Literature DB >> 15205644

Protamine and protamine reactions.

Kyung W Park1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15205644     DOI： 10.1097/00004311-200404230-00011

Source DB:  PubMed          Journal:  Int Anesthesiol Clin        ISSN： 0020-5907


× No keyword cloud information.
  15 in total

Review 1.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

2.  Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability.

Authors:  Ding Xu; Mark M Fuster; Roger Lawrence; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

3.  Venous thromboembolic disease.

Authors:  Michael B Streiff; Paula L Bockenstedt; Spero R Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z Goldhaber; Hani Hassoun; Paul Hendrie; Bjorn Holmstrom; Kimberly A Jones; Nicole Kuderer; Jason T Lee; Michael M Millenson; Anne T Neff; Thomas L Ortel; Judy L Smith; Gary C Yee; Anaadriana Zakarija
Journal:  J Natl Compr Canc Netw       Date:  2011-07-01       Impact factor: 11.908

4.  No need for systemic heparinization during laparoscopic donor nephrectomy with short warm ischemia time.

Authors:  Frank Friedersdorff; Ingmar Wolff; Serdar Deger; Jan Roigas; John Buckendahl; Hannes Cash; Markus Giessing; Lutz Liefeldt; Kurt Miller; Tom Florian Fuller; T Florian Fuller
Journal:  World J Urol       Date:  2011-05-24       Impact factor: 4.226

Review 5.  Are We Able to Dose Protamine Accurately Yet? A Review of the Protamine Conundrum.

Authors:  Patrick Hecht; Martin Besser; Florian Falter
Journal:  J Extra Corpor Technol       Date:  2020-03

6.  Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA.

Authors:  Manu Thomas Kalathottukaren; Libin Abraham; Piyushkumar R Kapopara; Benjamin F L Lai; Rajesh A Shenoi; Federico I Rosell; Edward M Conway; Edward L G Pryzdial; James H Morrissey; Charles A Haynes; Jayachandran N Kizhakkedathu
Journal:  Blood       Date:  2016-12-29       Impact factor: 22.113

7.  Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors.

Authors:  Manu T Kalathottukaren; A Louise Creagh; Srinivas Abbina; Genmin Lu; Mark J Karbarz; Anjali Pandey; Pamela B Conley; Jayachandran N Kizhakkedathu; Charles Haynes
Journal:  Blood Adv       Date:  2018-08-28

8.  Systemic heparinisation in laparoscopic live donor nephrectomy.

Authors:  Charlotte Crotty; Yasmin Tabbakh; Sarah A Hosgood; Michael L Nicholson
Journal:  J Transplant       Date:  2013-12-16

9.  Administration of Protamine Through Radial Arterial Access: A Prospective Observational Study.

Authors:  Priyanka Goyal; Sandeep Joshi; Monish S Raut
Journal:  Heart Views       Date:  2021-04-22

10.  Fatal right ventricular failure and pulmonary hypertension after protamine administration during cardiac transplantation.

Authors:  Bibek S Pannu; Devang K Sanghavi; Pramod K Guru; Dereddi Raja Reddy; Vivek N Iyer
Journal:  Indian J Crit Care Med       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.